Ferrer licenses commercialisation rights for Ozenoxacin in the United States to Medimetriks Pharmaceuticals Inc.
Ferrer, a privately-held Spanish pharmaceutical company today announces that it has licensed commercialisation rights for...
Provepharm¹s Japanese partner Daiichi Sankyo files an NDA to market the Methylene Blue injection...
Provepharm, a French company specialized in the development of pharmaceutical applications announces that Daiichi Sankyo,...
CiToxLAB appoints John C. Kapeghian as senior director of toxicology in North America
This appointment makes the Montreal site attractive to North American clients and boosts CiToxLAB’s expertise...
Adocia announces preliminary positive clinical results for its combination of long-acting insulin Glargine and...
Adocia’s BioChaperone Combo is the first product combining insulin Glargine with a fast-acting insulin analogPhase...
UBM to Launch Southeast Asia’s Leading International Beauty Trade Show In Thailand
BANGKOK Feb. 25 2014 - UBM Asia is pleased to announce the launch of ASEANbeauty...
The Most Complete Information on America’s Nursing Facilities
WASHINGTON: U.S. News & World Report publisher of Best Hospitals and Best Children's Hospitals today...
NBE-Therapeutics Announces Successful Validation of its SMAC™-Technology for the Generation of Antibody Drug Conjugates...
Basel, Switzerland, February 21, 2014 - NBE-Therapeutics (“NBE”) today announced that it has presented the...
Domain Therapeutics enters into collaboration with XOMA
DTect-All(TM) platform will be used to screen for GPCR-directed allosteric modulator antibodies Strasbourg, France, February...
Cellectis grants genOway an exclusive sublicense for its homologous recombination technology in the field...
The agreement covers the creation and sale of rodent animal models, the sale of existing...
TxCell to present an innovative, personalized cell-based immunotherapy approach at the 16th BIO CEO...
TxCell SA, a clinical stage biotechnology company developing innovative, personalized cell-based immunotherapies using antigen-specific regulatory...
